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The aim of this pilot cross-sectional study was to extensively investigate the relationships between cognitive performance and
motor dysfunction involving balance and gait ability in patients with Parkinson’s disease. Twenty subjects with Parkinson’s disease
underwent a cognitive (outcomes: Frontal Assessment Battery-Italian version,Montreal overall CognitiveAssessment, TrailMaking
Test, Semantic Verbal Fluency Test, and Memory with Interference Test) and motor (outcomes: Berg Balance Scale, 10-Meter
Walking Test, 6-Minute Walking Test, Timed Up and Go Test performed also under dual task condition, and Unified Parkinson’s
Disease Rating Scale) assessment. Our correlation analyses showed that balance skills are significantly correlated with executive
functions, cognitive impairment, and ability to switch attention between two tasks. Furthermore, functional mobility showed a
significant correlation with cognitive impairment, verbal fluency, and ability to switch attention between two tasks. In addition, the
functional mobility evaluated under the dual task condition showed a significant correlation with cognitive impairment and ability
to switch attention between two tasks. These findings might help early identification of cognitive deficits or motor dysfunctions in
patients with Parkinson’s disease who may benefit from rehabilitative strategies. Future prospective larger-scale studies are needed
to strengthen our results.
1. Introduction
Parkinson’s disease (PD) is an idiopathic neurodegenera-
tive disorder caused by a progressive loss of dopaminergic
neurons in the substantia nigra pars compacta [1]. Clinical
manifestations include reduced amplitude of movement,
hypokinesia, rigidity, resting tremor, and postural instability
[1, 2]. The resulting abnormal gait patterns raise the risk
of falls, with up to 63% of people with PD reporting more
than one fall per year [3]. In addition to motor symptoms,
about 25% of newly diagnosed PD sufferers present with
cognitive deficits [4] frequently involving attention, memory,
visuospatial, and executive functions in nondemented people
with PD [4–7]. Often, PD-associated cognitive deficits are
underestimated in daily clinical practice probably because
cognitive assessment is mainly based on the Mini Mental
State Examination (MMSE) that has low sensitivity for detect-
ing alterations in specific cognitive and executive functions
[8–11].
Internal generation ofmovement and executive functions
both require decision-making processes in order to select an
action among several alternative possibilities for the task at
hand. The basal ganglia (mostly modulated by dopaminergic
projections) seem to have an important role in the mediation
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of cognitive and motor modules to generate an appropriate
decision on a resulting action for the task being performed
[12]. Patients with PD showed a significant reduction of
the dopaminergic projections to the striatum [13]. Previous
studies indicate that executive deficits in PD patients without
dementia are associated with dysfunction of the caudate
nucleus [14–16], suggesting that dopamine is involved in the
transfer of information first processed in cognitive brain
networks, toward motor-related networks, sequentially [12].
Other potential factors that may influence the relationship
between cognitive and motor function in people with PD are
depression and age [17, 18].
Although cognitive-motor relationships have beenwidely
described in patients with PD, evaluation takes into con-
sideration a narrow range of outcome measures which do
not allow for in-depth complete assessment of cognitive
deficits and motor dysfunctions in PD [3, 19–23]. Hence,
a closer examination of cognitive-motor relationships is
needed to better define to what extent motor aspects depend
on cognitive ones and to inform the design of new treatment
protocols. Therefore, the aim of this study was to extensively
investigate the relationships between cognitive performance
and motor dysfunction involving balance and gait ability in
patients with PD.
2. Materials and Methods
This was a pilot cross-sectional study. Inclusion criteria
were confirmed diagnosis of idiopathic PD according to the
UK Brain Bank Criteria [24] and MMSE score > 24 [25].
Exclusion criteria were severe dyskinesias or on-off fluc-
tuations, severe comprehension deficit, psychotic disorders,
history of alcohol or drug abuse, deficits of somatic sensation
involving the lower limbs as assessed by neurological exami-
nation, vestibular disorders or paroxysmal vertigo, and other
neurological or orthopedic conditions involving the lower
limbs such as musculoskeletal diseases, severe osteoarthritis,
peripheral neuropathy, and joint replacement. All subjects
were outpatients and gave their informed written consent
to participate. The study was carried out according to the
Declaration of Helsinki and approved by the Local Ethics
Committee.
2.1. Evaluation Procedures. During the study period, subjects
were instructed to take their PD medications regularly.
Each subject underwent the following cognitive and motor
assessments during the “on” phase (1 to 2.5 hours after having
taken their morning dose). The same raters evaluated all
subjects (CF and SA performed the cognitive assessment; AP
and VZ performed the motor assessment) in an outpatients
clinical setting.
2.1.1. Cognitive Assessment. The main cognitive outcomes
were the Frontal Assessment Battery-Italian version (FAB-it)
[26] and theMontreal overall Cognitive Assessment (MoCA)
[11].
The FAB-it assesses executive functions such as con-
ceptualization, mental flexibility, programming, sensitivity
interference, inhibitory control, and environmental auton-
omy. It consists of 6 tests (similarities, lexical fluency, motor
series “Luria” test, conflicting instructions, go/no-go task, and
prehension behavior) each rated on a scale from 0 to 3 points.
The total score is the sum of all items; the range is from 0
(worst performance) to 18 (best performance) [26].
TheMoCA investigates patient’s skills in 5 domains: visu-
ospatial/executive, naming, memory, attention, abstraction,
and orientation.The total score is the sum of all items, with a
maximum score of 30 (best performance) [11].
Other cognitive outcomes were the Trail Making Test
(TMT), the Semantic Verbal Fluency Test (SVF), and the
Memory with Interference (MI) Test.
Attention capacity was evaluated with the TMT (parts
A and B) to assess selective attention, psychomotor speed,
and sequencing skills. Part B also investigates the ability to
switch attention between two rules or tasks.The time taken to
complete the trails is recorded (longer = worse performance)
[27].
The SVF assesses verbal fluency by determining the num-
ber of words pertaining to a specific semantic category that
subjects can spontaneously generate in 2 minutes (higher =
better performance) [28].
Workingmemory was assessed with theMI Test. Subjects
are asked to recall a consonant trigram after an interval
delay during which they have to count forward starting
from a 3-digit number randomly presented by the examiner
immediately after the trigram. At the end of an interval
delay of 10 seconds, subjects have to recall the trigram. The
maximum score is 9 (best performance) [29].
Besides cognitive skills, the patients’ mood was evaluated
through the Beck Depression Inventory. This tool consists of
21 items rated on a four-point scale of severity focusing on
psychological aspects of depression.The total score is the sum
of all items; the maximum score is 63 (worst mood) [30].
2.1.2. Motor Assessment. The main motor outcome was per-
formance on the Berg Balance Scale (BBS).This 14-item scale
(0–4 points/task; best score = 56) evaluates balance abilities
during sitting, standing, and positional changes [31].
Other motor outcomes were the 10-Meter Walking Test
(10MWT), the 6-Minute Walking Test (6MWT), the Timed
Up and Go Test (TUG), and the Unified Parkinson’s Disease
Rating Scale (UPDRS).
The 10MWT was selected as a measure of gait speed
[32, 33]. The subjects were asked to walk on a flat hard floor
at their fastest speed for 10m without assistance or the use
of walking aids (a 10m walkway was marked by two lines on
the floor at 2m and at 8m). In order tominimize acceleration
and deceleration, gait speedwasmeasured in the 6mbetween
the two marks (timing started when the toes of the leading
foot crossed the 2m mark and stopped when the toes of
the leading foot crossed the 8m mark) [32, 33]. Time was
measured using a handheld stopwatch.
Walking capacity was assessed using the 6MWT [34].The
subjects were asked to cover as much ground as possible in
6min (walking continuously at their possibly fastest speed
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without the use of walking aids) along a marked distance
(1 lap, 40m). The distance covered was recorded.
The TUG is functional mobility test associated with
balance problems and falls in older adults in which a subject
must stand up, walk 3 meters, turn around, walk back, and sit
down. The time taken to complete the test is correlated with
the level of functional mobility [35]. The subjects performed
the TUG under a dual task condition in which they were also
asked to count backwards from a randomly selected number
between 20 and 100 (TUG-COG) [36].
The UPDRS is a validated tool to follow the longitudinal
course of PD. It has 4 subsections. Part III (motor exami-
nation) was used (score ranges from 0 to 108; high = worst
performance) [37].
2.2. Statistical Analysis. Statistical analysis was carried out
using the Statistical Package for Social Sciences software, ver-
sion 20.0, for Macintosh (SPSS Inc, Chicago, IL). Spearman’s
rank correlation analysis was performed to determine the
correlation between motor and cognitive outcomes. Forward
stepwise multiple linear regression analyses were performed
to further clarify the relationship between cognitive outcomes
(the FAB-it, the MoCA, the SVF, and the TMT-B were
defined as independent variables), potential confounders (age
and the BDI were defined as independent variables), and
motor outcomes (the BBS, the TUG, and the TUG-COG
were defined as dependent variables). The alpha level for
significance was set at 𝑃 < 0.05.
3. Results
Twenty subjects (12 males, 8 females; mean age 70.3 ± 6.34
years; mean years of schooling 10.65 ± 5.19) presenting with
idiopathic PD (mean disease duration 9.88±5.79 years) were
recruited from among 46 outpatients consecutively admitted
to the Neurological Rehabilitation Unit of the Azienda
Ospedaliera Universitaria of Verona, Italy. The enrollment
period was from January to June 2014. Raw data of patients’
performance in all outcome measures are detailed in Table 1.
As to the motor-cognitive correlation in PD, the spear-
man’s analysis showed that the BBS was significantly directly
related to the FAB-it (𝑃 < 0.001 and 𝜌 = 0.790) and the
MoCA (𝑃 = 0.015 and 𝜌 = 0.534) and it was significantly
inversely related to the TMT-B (𝑃 = 0.005 and 𝜌 = −0.597).
The TUG was significantly inversely related to the MoCA
(𝑃 = 0.045 and 𝜌 = −0.564) and the SVF (𝑃 < 0.006 and
𝜌 = −0.713) and it was significantly directly related to the
TMT-B (𝑃 = 0.021 and 𝜌 = −0.630). The TUG-COG was
significantly inversely related to the MoCA (𝑃 = 0.025 and
𝜌 = −0.667) and significantly directly related to the TMT-B
(𝑃 < 0.020 and 𝜌 = 0.683) (see Table 2).
As reported in Table 3, the multiple linear regression
analysis showed a significant direct association between the
BBS and the FAB-it (𝑃 = 0.042; 𝛽 = 0.640).
4. Discussion
The aim of this pilot cross-sectional study was to perform an
in-depth investigation of the relationship between cognitive
Table 1: Raw data of patients’ performance in all outcomes.
FAB-it (0–18 points)
Median (IQR) 14.00 (11.75; 16.25)
MoCA (0–30 points)
Median (IQR) 22.00 (17.75; 25.25)
TMT-A (seconds)
Mean (SD) 155.20 (122.55)
TMT-B (seconds)
Mean (SD) 215.47 (103.07)
SVF (number of words)
Median (IQR) 17.50 (15.25; 22.00)
MI (0–9 points)
Median (IQR) 6.00 (3.00; 7.25)
BDI (0–63 points)
Median (IQR) 13.00 (7.50; 18.00)
MMSE (0–30 points)
Median (IQR) 29.00 (26.75; 30.00)
BBS (0–56 points)
Median (IQR) 44.50 (38.50; 49.00)
10MWT (seconds)
Mean (SD) 9.75 (4.65)
6MWT (meters)
Mean (SD) 298.77 (96.80)
TUG (seconds)
Mean (SD) 11.40 (4.84)
TUG-COG (seconds)
Mean (SD) 11.96 (2.99)
UPDRS III (0–108 points)
Median (IQR) 20.50 (16; 25.50)
SD, Standard Deviation; IQR, Interquartile Range; FAB-it, Frontal Assess-
ment Battery-Italian version; MoCA, Montreal overall Cognitive Assess-
ment; TMT, Trail Making Test; SVF: Semantic Verbal Fluency Test; MI,
Memory with Interference; BDI, Beck Depression Inventory; MMSE, Mini
Mental State Examination; BBS, Berg Balance Scale; 10MWT, 10-Meter
Walking Test; 6MWT, 6-Minute Walking Test; TUG, Timed Up and Go;
TUG-COG, Timed Up and Go under dual task condition; UPDRS III,
Unified Parkinson’s Disease Rating Scale, part III (motor examination).
deficits and motor dysfunctions involving balance and gait
ability in patients with PD. We found that balance skills
(as measured by the BBS) are significantly correlated with
executive functions (as measured by the FAB-it), cognitive
impairment (asmeasured by theMoCA), and ability to switch
attention between two tasks (as measured by the TMT-B).
Furthermore, functional mobility (as measured by the TUG)
showed a significant correlation with cognitive impairment
(as measured by the MoCA), verbal fluency (as measured by
the SVF), and ability to switch attention between two tasks
(as measured by the TMT-B). In addition, the functional
mobility evaluated under the dual task condition (as mea-
sured by the TUG-COG) showed a significant correlation
with cognitive impairment (as measured by the MoCA) and
ability to switch attention between two tasks (as measured by
the TMT-B).
Despite the fact that cognitive-motor relationships have
been previously reported in PD [3, 19–23], many of these
studies did not extensively investigate motor or cognitive
functions [3, 19, 22, 23]. For example, Lee and colleagues
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Table 2: Correlation matrix for study variables (Spearman’s rho).
Outcome
measures FAB-it MoCA TMT-A TMT-B SVF MI BDI BBS 10MWT 6MWT TUG TUG-COG UPDRS III
FAB-it 1.000
MoCA 0.715∗ 1.000
TMT-A −0.517∗ −0.776∗ 1.000
TMT-B −0.704∗ 0.822∗ 0.740∗ 1.000
SVF 0.583∗ 0.778∗ −0.579∗ −0.729∗ 1.000
MI 0.596∗ 0.664∗ −0.511∗ −0.553∗ 0.736∗ 1.000
BDI 0.001 −0.106 0.223 0.030 0.133 −0.029 1.000
BBS 0.790∗ 0.534∗ −0.304 −0.597∗ 0.371 0.283 −0.114 1.000
10MWT −0.138 −0.090 0.114 0.308 −0.313 −0.146 −0.371 −0.169 1.000
6MWT 0.149 0.058 −0.129 −0.095 0.292 0.082 −0.014 0.429 −0.715 1.000
TUG −0.372 −0.564∗ 0.477 0.630∗ −0.713∗ −0.243 −0.102 −0.499 0.762∗ −0.709∗ 1.000
TUG-COG 0.190 −0.667∗ 0.392 0.683∗ −0.538 0.101 −0.192 −0.303 0.228 0.027 0.727∗ 1.000
UPDRS III −0.281 −0.035 −0.072 0.077 0.088 0.272 −0.103 −0.427 −0.029 0.135 0.074 0.606∗ 1.000
FAB-it, Frontal Assessment Battery-Italian version; MoCA, Montreal overall Cognitive Assessment; TMT, Trail Making Test; SVF, Semantic Verbal Fluency;
MI, Memory with Interference Test; BDI, Beck Depression Inventory; BBS, Berg Balance Scale; 10MWT, 10-Meter Walking Test; 6MWT, 6-Minute Walking
Test; TUG, Timed Up and Go Test; TUG-COG, Timed Up and Go Test under dual task condition; UPDRS III, Unified Parkinson’s Disease Rating Scale part
III (motor examination).
∗Significant correlation (𝑃 < 0.05).
Table 3: Multiple linear regression analysis.
Dependent variables Independent variables
FAB-it MoCA TMT-B SVF Age BDI
BBS
𝛽 0.640 0.269 −0.117 −0.309 0.027 0.094
𝑃 0.042∗ 0.481 0.745 0.322 0.892 0.635
TUG
𝛽 −0.661 −0.289 −0.086 0.126 −0.124 −0.084
𝑃 0.259 0.704 0.908 0.814 0.748 0.821
TUG-COG
𝛽 0.148 −0.719 −0.229 −0.548 −0.322 0.005
𝑃 0.690 0.223 0.679 0.320 0.307 0.991
FAB-it, Frontal Assessment Battery-Italian version; MoCA, Montreal overall Cognitive Assessment; TMT, Trail Making Test; SVF, Semantic Verbal Fluency;
BDI, Beck Depression Inventory; BBS, Berg Balance Scale; TUG, Timed Up and Go Test; TUG-COG, Timed Up and Go Test under dual task condition.
∗Significant correlation (𝑃 < 0.05).
examined only the postural instability skill. Specifically they
investigated the relationship between postural instability, as
measured by computerized dynamic posturography, and cog-
nitive impairment and found a correlation between balance
abilities and MMSE scores. They demonstrated a significant
correlation between equilibrium scores and visuospatial and
memory functions [22]. In an earlier study, Yogev and
coworkers investigated only the relationship between gait
ability and cognitive function. They found that executive
function measures were significantly correlated with gait
variability during dual tasking [23]. Allcock and colleagues,
regarding cognitive abilities, investigated only attention skills
and found an association between fall frequency and atten-
tion [3]. Williams and coworkers’ study correlated motor
abilities only with cognitive screening test scores, finding a
relation between postural/gait instability and theMMSE [19].
Unlike these studies, more recent research has inves-
tigated other aspects of cognitive and motor performance
in patients with PD and analyzed their correlations [20,
21]. Specifically, Domello¨f and colleagues explored which
aspects of cognition (memory, psychomotor speed, attention,
language, visuospatial abilities, and executive functions) are
connected to different motor signs as investigated by the
UPDRS [20]. They found that bradykinesia was associated
with executive functions (working memory and mental
flexibility), whereas axial signs (such as postural instability,
gait disturbances, and bulbar dysfunctions) were associated
with memory and visuospatial abilities [20]. Similarly, Poletti
and colleagues reported that the bradykinesia score on the
UPDRS predicted performances on the executive tasks. But
differently from Domello¨f and colleagues’ study, correla-
tion analyses revealed that axial signs were also associated
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with executive deficits [21]. This result is in line with our
data. Poletti and colleagues evaluated balance performance
according to the UPDRS. It should be noted, however, that
the UPDRS is a qualitative test that may be inadequate
for accurately estimating balance and gait performance due
to the subjective nature of the evaluation and the lack of
normative criteria [38, 39]. Therefore, scales that yield a
more varied estimate of posture and gait control are needed
to obtain a better overall estimate of quantitative postural
control, as we have done. Furthermore, this aspect could
explain the differences in results between Domello¨f and
colleagues’ and Poletti and coworkers’ studies.
Similarly important is to extensively evaluate cognitive
skills in patients with PD. In our view, the cognitive per-
formance of patients with PD should be assessed by specific
and appropriate cognitivemeasures in addition to theMMSE,
considering that this examination alone does not allow
identifying specific deficits in executive functions that are
usually impaired in patients with PD [8–10].
Interestingly, our regression analyses showed a significant
association between balance skills (as measured by the BBS)
and executive functions (as measured by the FAB-it). From
a rehabilitation point of view, it may be useful to clarify
these aspects of the association between cognitive deficits
and motor dysfunction in patients with PD in order to
develop more appropriate rehabilitation programs that also
include ecological situations for trainingmotor and cognitive
functions. In this context, prospective studies are needed to
further investigate the effects of cognitive training on motor
performance.
This study has several limitations. The main one is the
small sample size that may have missed some aspects of
the relationship between cognitive impairment and motor
disorders in the correlation and regression analyses. Second,
we excluded patients with MMSE score < 24; thus our
population and results are limited to a relatively normal
cognitive function for age. Third, we did not assess memory
functions. Fourth, because we did not investigate patients in
the “off” phase, we cannot draw conclusions about cognitive-
motor relationships in the unmedicated state. Fifth, we did
not include instrumental evaluations of gait and balance
parameters.
5. Conclusions
Our findings have some clinical implications. Indeed, they
may help early identification of cognitive deficits or motor
dysfunctions in patients with PDwhomay benefit from reha-
bilitative strategies. Future prospective larger-scale studies
including other instrumental motor outcomes are needed
to strengthen our results and better explore the effects of
training on cognitive-motor relationships in patients with
PD.
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